AUSTIN, Texas, and CHARLESTON, S.C. - The Medical University of South Carolina (MUSC), a nationally leading academic health system with a growing innovation ecosystem, today announced a strategic partnership/collaboration designed to accelerate evaluation, development and clinical advancement of next-generation medical technologies with Revival Healthcare Capital, an investment firm focused on transformative external innovation partnerships in medical devices.
Under the five-year agreement, MUSC and Revival will establish a scalable collaboration model that enables rapid activation of project-specific initiatives.
As part of the collaboration, MUSC clinicians and subject-matter experts may provide clinical and procedural insights to inform the evaluation of technologies aligned with Revival’s investment strategy. In addition, MUSC leaders may serve as advisors to Revival portfolio companies, providing clinical and health system validation to help accelerate the product development lifecycle.
MUSC’s innovation ecosystem is focused on translating scientific discovery and clinical insight into scalable solutions. This partnership with Revival is intended to complement MUSC’s innovation mission by creating a clearer pathway for capital, operational expertise and industry alignment.
The collaboration also creates a pathway for Revival to evaluate select MUSC-originated medical device opportunities. Revival’s investment approach and partners could support later stage clinical development and the advancement of medical device innovation.
“This collaboration reflects MUSC’s commitment to advancing innovation that improves patient care and health outcomes,” said David J. Cole, M.D., FACS, president of MUSC. “By working closely with Revival Healthcare Capital, our clinicians and researchers can help evaluate and inform the development of promising medical technologies, strengthening the pathway from clinical insight to real‑world impact.”
“We are pleased to partner with MUSC to create a repeatable, high-velocity collaboration model that supports our investment strategy and our portfolio companies,” said Todd M. Pope, senior partner at Revival Healthcare Capital. “By combining Revival’s flexible capital model and operational capabilities with MUSC’s strong collaboration across patient care, research and education, we believe this partnership can advance technologies that address unmet patient needs.”